Related Experiment Video

Updated: Aug 19, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

[Primary congenital glaucoma]

Jaime Levy1, Zvi Tessler, Oren Tamir

  • 1Department of Ophthalmology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel. ljaime@bgumail.bgu.ac.il

Harefuah
|January 26, 2005
PubMed

Insights

Primary congenital glaucoma (PCG) is a rare genetic eye disease affecting newborns due to abnormal eye development. Mutations in the cytochrome P4501B1 gene are linked to PCG, often requiring surgery and lifelong monitoring.

Area of Science:

  • Ophthalmology
  • Genetics
  • Pediatrics

Context:

  • Primary congenital glaucoma (PCG) is a rare genetic disorder impacting infants.
  • It stems from developmental anomalies in the eye's drainage system, leading to elevated intraocular pressure.
  • Incidence varies, with higher rates in specific populations like the Arab-Bedouin community in Israel.

Purpose:

  • To summarize the key aspects of primary congenital glaucoma.
  • To highlight the genetic basis, clinical presentation, and management of PCG.
  • To underscore the importance of early diagnosis and lifelong follow-up for affected children.

Summary:

  • PCG is characterized by abnormal anterior chamber development, obstructing aqueous humor outflow and increasing intraocular pressure.
  • Classical symptoms include epiphora, photophobia, and blepharospasm, often necessitating examination under general anesthesia.
  • Mutations in the cytochrome P4501B1 gene are a primary cause of PCG.
  • Surgical intervention is the mainstay of treatment, with medical management as a temporary measure.
  • A significant percentage of infants with PCG face severe vision impairment, emphasizing the need for continuous monitoring.

Impact:

  • Early diagnosis and surgical management of PCG are crucial to prevent irreversible vision loss.
  • Understanding the genetic underpinnings of PCG aids in genetic counseling and potential future targeted therapies.
  • Lifelong follow-up is essential for managing complications and monitoring disease progression in PCG patients.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...